Effects of NT-814, a dual neurokinin 1 and 3 receptor antagonist, on vasomotor symptoms in postmenopausal women: a placebo-controlled, randomized controlled trial

Mike Trower, Richard Anderson, Elizabeth Ballantyne, Hadine Joffe, Mary Kerr, Steve Pawsey

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Publication statusPublished - 1 May 2020

Cite this